CEBPD was suggested to respond to many anticancer drugs and to contribute to apoptosis induced by these anticancer drugs.38, 39 The anticancer drug bortezomib was originally suggested to serve as a proteasome inhibitor and a common therapeutic drug of leukemia. Here, CEBPD is linked to leukemia.